Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 -- Mainstreaming Addiction Treatment Act of 2021 - monitoring introduction of bill designed to ease restrictions on prescribing medications for the treatment of substance use disorder.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PURDUE PHARMA LP via PURDUE PHARMA, LP
2022 · second_quarter · Q2
Monitored congressional activity related to Medicare, Medicaid, PDUFA, public health, mental health and substance use disorder treatment.
Monitored congressional activity related to bankruptcy reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Mainstreaming Addiction Treatment Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Mainstreaming Addiction Treatment Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Mainstreaming Addiction Treatment Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 -- Mainstreaming Addiction Treatment Act of 2021 - monitoring introduction of bill designed to ease restrictions on prescribing medications for the treatment of substance use disorder.
Mainstreaming Addiction Treatment Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Nondebtor Release Prohibition Act of 2021
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Block, Report, And Suspend Suspicious Shipments Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs.
Pharmaceutical Independence Long-Term Readiness Reform Act
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Debarment Enforcement of Bad Actor Registrants Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Ensuring Compliance Against Drug Diversion Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs.
Strengthening America's Strategic National Stockpile Act of 2020
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Preventing Pill Mills Through Data Sharing Act
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Prescription Drug Pricing Reduction Act of 2019
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Prescription Drug Pricing Reduction Act of 2019
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Prescription Drug Pricing Reduction Act of 2019
Client: PURDUE PHARMA LP · Firm: PURDUE PHARMA, LP
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs.
2022 · first_quarter · 1A
Monitored congressional activity related to bankruptcy reform.
Monitored congressional activity related to Medicare, Medicaid, PDUFA, public health, mental health and substance use disorder treatment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2021 · fourth_quarter · Q4
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored congressional activity relating to coverage requirements, employer healthcare-related issues, and public health matters relating to pandemic preparedness and response.
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2021 · third_quarter · Q3
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Monitored congressional activity relating to coverage requirements, employer healthcare-related issues, and public health matters relating to pandemic preparedness and response.
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2021 · second_quarter · Q2
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2021 · first_quarter · Q1
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 -- Mainstreaming Addiction Treatment Act of 2021 - monitoring introduction of bill designed to ease restrictions on prescribing medications for the treatment of substance use disorder.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2020 · fourth_quarter · Q4
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2020 · third_quarter · Q3
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs. H.R. 7574 - The Strengthening America's Strategic National Stockpile Act of 2020; monitoring activity to better understand what modifications may be made to medications required to be included as part of national stockpile. H.R. 3878 - The Block, Report, And Suspend Shipments Act of 2019, H.R. 4812 Ensuring Compliance Against Drug Diversion Act of 2019, and H.R. 4806 DEBAR Act of 2019; monitoring activity on these bills as it relates to potential modifications to DEA registration procedures and reporting.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PURDUE PHARMA LP via PURDUE PHARMA, LP
2020 · second_quarter · Q2
H.R.4710 - Pharmaceutical Independence Long-Term Readiness Reform Act and H.R.6482 - Protecting Our Pharmaceutical Supply Chain from China Act of 2020; monitoring activity regarding potential incentives to increase domestic manufacturing of pharmaceutical products. S. 2543 Prescription Drug Pricing Reduction Act of 2019; monitoring to understand potential new obligations on pharmaceutical manufacturers regarding price transparency and implications for applicable federal programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE